Back
U
University of Rochester Medicine
Scholars118
Papers42
Citations0
Related Papers (61)
Publication Date
A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older
EBioMedicine
IF10.8

